Loading…

Inhibition of Bacterial Neuraminidase and Biofilm Formation by Ugonins Isolated From Helminthostachys Zeylanica (L.) Hook

Bacterial neuraminidase (BNA) plays a pivotal role in the pathogenesis of several microbial diseases including biofilm formation. The aim of this study is to reveal the neuraminidase inhibitory potential of metabolites from (L.) Hook. which have diverse biological activities including PTP1B and -glu...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in pharmacology 2022-05, Vol.13, p.890649-890649
Main Authors: Shah, Abdul Bari, Baiseitova, Aizhamal, Kim, Jeong Ho, Lee, Yong Hyun, Park, Ki Hun
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bacterial neuraminidase (BNA) plays a pivotal role in the pathogenesis of several microbial diseases including biofilm formation. The aim of this study is to reveal the neuraminidase inhibitory potential of metabolites from (L.) Hook. which have diverse biological activities including PTP1B and -glucosidase. The six ugonins ( ) from the target plant showed significant neuraminidase inhibition. The inhibitory potencies were observed at a nanomolar level of 35-50 nM, which means they are 100 times more active than their corresponding mother compounds (eriodyctiol and luteolin). A detailed kinetic study revealed that all ugonins were reversible noncompetitive inhibitors. An in-depth investigation of the most potent compound showed its time-dependent inhibition with the isomerization model having = 0.0103 min , = 0.0486 min , and = 0.062 μM. The binding affinities ( ) were agreed closely with our prediction based on the inhibitory potencies. Particularly, ugonin J ( ) blocked the biofilm formation of dose-dependently up to 150 µM without the inhibition of bacteria. The major compounds ( ) in the extract were characterized by UPLC-ESI-Q-TOF/MS.
ISSN:1663-9812
1663-9812
DOI:10.3389/fphar.2022.890649